SCHEMBL4929402

SCHEMBL4929402

O=C(O)c1ccc(C#CC2(NC(=O)c3cc4ccccc4o3)CCNCC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.51
SMN1; SMN2 Q16637 5/20 0.51
NPC1 O15118 4/20 0.51
TP53 P04637 3/20 0.51
PKM P14618 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42
RELA Q04206 1/20 0.42
GALK1 P51570 1/20 0.42
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
ALDH1A1 P00352 4/20 0.41
HPGD P15428 2/20 0.41
BCAT1 P54687 1/20 0.40
TSHR P16473 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MAPK1 P28482 1/20 0.39
MIF P14174 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5497379 0.91 TDP1 (0.43) RAB9ASMN1; SMN2NPC1TP53PKM
Hydrochloric Acid SCHEMBL4819148 0.90 TDP1 (0.42) RAB9ASMN1; SMN2NPC1TP53PKM
SCHEMBL4816912 0.90 KMT2A (0.48) RAB9ASMN1; SMN2NPC1TP53TDP1
SCHEMBL4248565 0.89 RAB9A (0.39) RAB9ASMN1; SMN2NPC1TP53PKM
Hydrochloric Acid SCHEMBL4817981 0.89 KMT2A (0.48) RAB9ASMN1; SMN2NPC1TP53TDP1
SCHEMBL4808840 0.84 TDP1 (0.46) RAB9ASMN1; SMN2NPC1TP53PKM
SCHEMBL4809405 0.82 TDP1 (0.45) RAB9ASMN1; SMN2NPC1TP53PKM
SCHEMBL4258421 0.81 RAB9A (0.42) RAB9ASMN1; SMN2NPC1TP53PKM
SCHEMBL4815983 0.81 TDP1 (0.44) RAB9ASMN1; SMN2NPC1TP53PKM
SCHEMBL4818988 0.81 TDP1 (0.44) RAB9ASMN1; SMN2NPC1TP53PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080248506-A1 Method of Monitoring Anti-Tumor Activity of an Hdac Inhibitor PHARMACYCLICS, INC. (US) 2008-10-09 US disclosed
WO-2006042035-A2 METHOD OF MONITORING ANTI-TUMOR ACTIVITY OF AN HDAC INHIBITOR PHARMACYCLICS, INC. (US) 2006-04-20 WO disclosed